AS
Abdullah Saleh Salmen Anooz Al Ameri
About Abdullah Saleh Salmen Anooz Al Ameri
Data last updated:
Abdullah Saleh Salmen Anooz Al Ameri is a Director at Orange Medipharmaceuticals Private Limited (since 2017). The company operates in Pharma. Orange Medipharmaceuticals Private Limited reported revenue of ₹74.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orange Medipharmaceuticals Private Limited U24233UP2015PTC074326 | Director | 17 May 2017 | 2015 | ₹74.4 Lakh (FY 2024) | Active |
Board colleagues of Abdullah Saleh Salmen Anooz Al Ameri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Humera Yaseen | 07155931 | Orange Medipharmaceuticals Private Limited | Director |
| Imran Ahmad Ansari | 07155732 | Orange Medipharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abdullah Saleh Salmen Anooz Al Ameri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abdullah Saleh Salmen Anooz Al Ameri
Abdullah Saleh Salmen Anooz Al Ameri currently holds 1 directorship: Orange Medipharmaceuticals Private Limited (Director, since 17 May 2017, revenue ₹74.4 Lakh (FY 2024)).
Abdullah Saleh Salmen Anooz Al Ameri was first appointed on 17 May 2017 as Director at Orange Medipharmaceuticals Private Limited.
The current boards of Abdullah Saleh Salmen Anooz Al Ameri's companies include Humera Yaseen (Orange Medipharmaceuticals Private Limited), Imran Ahmad Ansari (Orange Medipharmaceuticals Private Limited).